Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study

1. Zeuzem, S.
2. Mantry, P.
3. Soriano, V.
4. Buynak, R.J.
5. Dufour, J.-F.
6. Pockros, P.J.
7. Wright, D.
8. Angus, P.
9. Buti, M.
10. Stern, J.O.
11. Kadus, W.
12. Vinisko, R.
13. Böcher, W.
14. Mensa, F.J.